Publication Information

{'id': 'https://openalex.org/W2359573293', 'doi': None, 'title': 'Biochemical process of AGEs formation in complications of hyperglycemia-induced diabetes and its pathological damage effects: A possible target for new drugs', 'display_name': 'Biochemical process of AGEs formation in complications of hyperglycemia-induced diabetes and its pathological damage effects: A possible target for new drugs', 'publication_year': 2003, 'publication_date': '2003-01-01', 'ids': {'openalex': 'https://openalex.org/W2359573293', 'mag': '2359573293'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-MYXZ2003S1031.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764367629', 'display_name': 'Immunological Journal', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4361730452', 'host_organization_name': 'Army Medical University', 'host_organization_lineage': ['https://openalex.org/P4361730452'], 'host_organization_lineage_names': ['Army Medical University'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5053656744', 'display_name': 'Xiao He', 'orcid': 'https://orcid.org/0000-0002-5188-4382'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Xiao He', 'raw_affiliation_strings': ['-Ian, XU Zhe, CAI Guo-ping'], 'affiliations': [{'raw_affiliation_string': '-Ian, XU Zhe, CAI Guo-ping', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5053656744'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 59}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11142', 'display_name': 'Advanced Glycation End Products research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1308', 'display_name': 'Clinical Biochemistry'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11142', 'display_name': 'Advanced Glycation End Products research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1308', 'display_name': 'Clinical Biochemistry'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10408', 'display_name': 'Chronic Kidney Disease and Diabetes', 'score': 0.9811, 'subfield': {'id': 'https://openalex.org/subfields/2727', 'display_name': 'Nephrology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11140', 'display_name': 'Natural Antidiabetic Agents Studies', 'score': 0.9631, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/rage', 'display_name': 'RAGE', 'score': 0.68186784}, {'id': 'https://openalex.org/keywords/advanced-glycation-end-product', 'display_name': 'Advanced glycation end-product', 'score': 0.535046}], 'concepts': [{'id': 'https://openalex.org/C147990577', 'wikidata': 'https://www.wikidata.org/wiki/Q25790', 'display_name': 'Glycation', 'level': 3, 'score': 0.8743602}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.71197313}, {'id': 'https://openalex.org/C2778857457', 'wikidata': 'https://www.wikidata.org/wiki/Q153641', 'display_name': 'Rage (emotion)', 'level': 2, 'score': 0.68186784}, {'id': 'https://openalex.org/C2776151105', 'wikidata': 'https://www.wikidata.org/wiki/Q898814', 'display_name': 'Oxidative stress', 'level': 2, 'score': 0.5840933}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5685302}, {'id': 'https://openalex.org/C2776997535', 'wikidata': 'https://www.wikidata.org/wiki/Q2556837', 'display_name': 'Advanced glycation end-product', 'level': 4, 'score': 0.535046}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.48095885}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4707499}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.43358094}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.19163594}, {'id': 'https://openalex.org/C169760540', 'wikidata': 'https://www.wikidata.org/wiki/Q207011', 'display_name': 'Neuroscience', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-MYXZ2003S1031.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764367629', 'display_name': 'Immunological Journal', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4361730452', 'host_organization_name': 'Army Medical University', 'host_organization_lineage': ['https://openalex.org/P4361730452'], 'host_organization_lineage_names': ['Army Medical University'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.82, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3032592562', 'https://openalex.org/W2888680705', 'https://openalex.org/W2793316160', 'https://openalex.org/W2792270945', 'https://openalex.org/W2766517560', 'https://openalex.org/W2740617459', 'https://openalex.org/W2601156194', 'https://openalex.org/W2473695612', 'https://openalex.org/W2388779496', 'https://openalex.org/W2318459355', 'https://openalex.org/W2215895942', 'https://openalex.org/W2176343920', 'https://openalex.org/W2120293565', 'https://openalex.org/W2118332826', 'https://openalex.org/W2114814727', 'https://openalex.org/W2107243407', 'https://openalex.org/W1976976849', 'https://openalex.org/W1908050450', 'https://openalex.org/W1521445505', 'https://openalex.org/W129095349'], 'abstract_inverted_index': {'Advanced': [0], 'glycation': [1], 'end-products': [2], '(AGEs)': [3], 'are': [4, 158], 'closely': [5], 'related': [6], 'to': [7, 62, 74], 'diabetes': [8], 'mellitus': [9], 'and': [10, 26, 40, 59, 93, 113, 142, 149, 206], 'complications': [11, 30, 126], 'of': [12, 20, 31, 77, 84, 88, 95, 105, 120, 140, 147, 163, 212, 221], 'diabetes.': [13], 'This': [14], 'article': [15], 'reviews': [16], 'the': [17, 89, 118, 138, 145, 177], 'biochemical': [18], 'process': [19], 'AGEs': [21, 64, 72, 99, 111, 122, 141, 173, 178, 191, 213], 'formation,': [22], 'its': [23], 'structure,': [24], 'function,': [25], 'pathological': [27, 67], 'effects': [28], 'on': [29], 'hyperglycemia-induced': [32, 124], 'diabetes,': [33], 'such': [34], 'as': [35, 109], 'cardiovascular': [36], 'complications,': [37], 'retinopathy,': [38], 'neuropathy': [39], 'nephropathy.': [41], 'Reducing': [42], 'sugars': [43], 'react': [44], 'non-enzymatically': [45], 'with': [46], 'ami': [47], 'no': [48], 'groups': [49], 'in': [50, 190], 'proteins': [51], 'through': [52], 'Maillard': [53], 'reaction': [54], 'by': [55, 71, 180, 197, 202, 215, 224], 'forming': [56], 'Schiff': [57], 'bases': [58], 'Amadori': [60], 'products': [61], 'produce': [63], 'irreversibly.': [65], 'The': [66, 184, 208], 'crosslink': [68], 'formation': [69, 174, 179], 'induced': [70], 'leads': [73], 'increased': [75], 'stiffness': [76], 'protein': [78], 'matrix,': [79], 'which': [80, 193], 'will': [81], 'cause': [82, 123], 'sclerosis': [83], 'renal': [85], 'glomerulus,': [86], 'thickening': [87], 'capillary': [90], 'basement': [91], 'membrane': [92], 'development': [94], 'arteriosclerosis.': [96], 'Receptor': [97], 'for': [98, 171, 234], '(RAGE)': [100], ',': [101], 'a': [102, 188, 230], 'multiligand': [103], 'member': [104], 'immunoglobulin': [106], 'su-perfamily,': [107], 'acts': [108], 'an': [110], 'scavenger': [112], 'mediates': [114], 'intracellular': [115], 'signaling.': [116], 'Although': [117], 'mechanism': [119], 'how': [121], 'diabetic': [125], 'is': [127, 187, 210], 'not': [128], 'fully': [129], 'understood,': [130], 'three': [131, 161], 'possible': [132], 'pathways': [133], 'have': [134], 'been': [135], 'proposed:': [136], '(1)': [137], 'cross-link': [139, 182, 199], 'proteins;': [143], '(2)': [144], 'interaction': [146], 'AGE-RAGE': [148], 'cellular': [150, 204], 'biosignal': [151], 'transduction;': [152], '(3)': [153], 'oxidative': [154], 'stress.': [155], 'Nowadays': [156], 'there': [157], 'at': [159, 166], 'least': [160], 'strategies': [162], 'treatments': [164], 'aiming': [165], 'AGEs.': [167], 'Firstly,': [168], 'therapeutic': [169], 'interventions': [170], 'reducing': [172, 181], 'should': [175], 'stress': [176], 'formation.': [183], 'second': [185], 'strategy': [186], 'reduction': [189], 'deposition,': [192], 'might': [194], 'be': [195], 'achieved': [196], 'using': [198, 216, 225], 'breakers': [200], 'or': [201, 219], 'enhancing': [203], 'uptake': [205], 'degradation.': [207], 'third': [209], 'inhibition': [211], 'receptor': [214], 'neutralizing': [217], 'antibodies,': [218], 'suppression': [220], 'post-receptor': [222], 'signaling': [223], 'antioxi-dants.': [226], 'All': [227], 'these': [228], 'provide': [229], 'new': [231], 'conceptual': [232], 'framework': [233], 'future': [235], 'drug': [236], 'discovery.': [237]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2359573293', 'counts_by_year': [], 'updated_date': '2024-12-15T02:47:56.453684', 'created_date': '2016-06-24'}